When do You Stop a Cholinesterase Inhibitor in Alzheimer’s disease?

Abstract

Henry Brodaty is Professor of Ageing and Mental Health and Director of the Australian government-funded Primary Dementia Collaborative Research Centre at the University of New South Wales in Sydney, Australia. He is Director of Aged Care Psychiatry and Head of the Memory Disorders Clinic at the Prince of Wales Hospital in Sydney, Australia, where he also directs a center conducting trials of drugs for the treatment of Alzheimer’s disease. Professor Brodaty is a past president of Alzheimer’s Australia and Alzheimer’s Australia (NSW) and past Chairman of Alzheimer’s Disease International and of its Medical and Scientific Panel. He has published over 300 scientific papers and several books. Professor Brodaty’s research interests include prevention and treatment of Alzheimer’s disease, the conceptualization of mild cognitive impairment, how best to help family caregivers, how best to care for people with dementia in nursing homes and the etiology and management of behavioral and psychological symptoms of dementia. He is committed to improving the quality of life of people with dementia and their families through direct services, advocacy and advancing research.